Zevra Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell ZVRA and other ETFs, options, and stocks.About ZVRA
Zevra Therapeutics, Inc. is a commercial-stage rare disease company that combines science, data and patient needs to create therapies for diseases with limited or no treatment options. The firm focuses on the treatment of rare neurological and sleep conditions such as certain Urea Cycle Disorders, Niemann Pick Disease Type C and Idiopathic Hypersomnia.
CEONeil F. McFarlane
CEONeil F. McFarlane
Employees59
Employees59
HeadquartersCelebration, Florida
HeadquartersCelebration, Florida
Founded2006
Founded2006
Employees59
Employees59
ZVRA Key Statistics
Market cap486.97M
Market cap486.97M
Price-Earnings ratio13.82
Price-Earnings ratio13.82
Dividend yield—
Dividend yield—
Average volume1.32M
Average volume1.32M
High today$8.80
High today$8.80
Low today$8.48
Low today$8.48
Open price$8.70
Open price$8.70
Volume823.77K
Volume823.77K
52 Week high$13.16
52 Week high$13.16
52 Week low$6.19
52 Week low$6.19
Stock Snapshot
With a market cap of 486.97M, Zevra Therapeutics(ZVRA) trades at $8.80. The stock has a price-to-earnings ratio of 13.82.
On 2025-12-04, Zevra Therapeutics(ZVRA) stock moved within a range of $8.48 to $8.80. With shares now at $8.80, the stock is trading +3.8% above its intraday low and 0.0% below the session's peak.
Trading activity shows a volume of 823.77K, compared to an average daily volume of 1.32M.
Over the past 52 weeks, Zevra Therapeutics(ZVRA) stock has traded between a high of $13.16 and a low of $6.19.
Over the past 52 weeks, Zevra Therapeutics(ZVRA) stock has traded between a high of $13.16 and a low of $6.19.
Analyst ratings
100%
of 9 ratingsBuy
100%
Hold
0%
Sell
0%
People also own
Based on the portfolios of people who own ZVRA. This list is generated using Robinhood data, and it’s not a recommendation.